Top Analyst Upgrades and Downgrades: Amazon, Anthem, Constellation Brands, Hecla, Nike, Overstock.com, UnitedHealth and More

Print Email

Stocks were indicated to open higher on Monday after a choppy prior week. Investors have seen less upside when they have bought the market pullbacks than in prior years, and investors need to be considering how they want their investments positioned for the rest of 2018.

24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new investing and trading ideas for our readers. Some analyst reports cover stocks to buy, but some cover stocks to sell or to avoid.

Additional commentary has been added on most of the daily analyst reports, along with trading history. The consensus analyst price targets and other valuation metrics are from the Thomson Reuters sell-side research service.

These are the top analyst upgrades, downgrades and initiations seen on Monday, September 10, 2018.

Akamai Technologies Inc. (NASDAQ: AKAM) was raised to Buy from Neutral and the price target was raised to $93 from $80 (versus a $74.51 prior close) at D.A. Davidson.

Amazon.com Inc. (NASDAQ: AMZN) was reiterated as Buy and the price target was raised to $2,250 from $2,100 at Citigroup. Amazon shares closed down 0.3% at $1952.07 on Friday and were indicated up 0.8% at $1968.50 on Monday.

American Electric Power Co. (NYSE: AEP) was maintained as Neutral but the price target was raised to $72 from $71 at Citigroup.

Anthem Inc. (NYSE: ANTM) was downgraded to Neutral from Buy with a $290 price target (versus a $271.90 close) at Citigroup.

Constellation Brands Inc. (NYSE: STZ) was downgraded to Hold from Buy and the price target was lowered to $220 from $260 (versus a $211.72 close) at SunTrust Robinson Humphrey.

Foot Locker Inc. (NYSE: FL) was raised to Outperform from Market Perform and the target was raised to $58 from $50 (versus a $46.74 close) at Wells Fargo.

Hecla Mining Co. (NYSE: HL) was started with a Buy rating and assigned a $5 price target (versus a $2.71 close) at Roth Capital. The stock was indicated up almost 2% at $2.76 on Monday, and it has a consensus target price of $4.29.

Inogen Inc. (NASDAQ: INGN) was downgraded to Buy from Strong Buy at Needham.

Neurocrine Biosciences Inc. (NASDAQ: NBIX) was started as Overweight and assigned a $145 target price (versus a $116.93 close) at Morgan Stanley.

Nike Inc. (NYSE: NKE) was reiterated as Outperform and the price target was raised to $90 from $85 (versus an $80.30 close) at Wedbush Securities.

Overstock.com Inc. (NASDAQ: OSTK) was started as Buy with a $75 price target (versus a $26.00 close) at Maxim Group. The 52-week range is $23.10 to $89.80, and shares were indicated up almost 6% at $27.50 on Monday.

Taubman Centers Inc. (NYSE: TCO) was downgraded to Underperform from In-Line at Evercore ISI.

Texas Roadhouse Inc. (NASDAQ: TXRH) was downgraded to Neutral from Outperform at Wedbush.

UnitedHealth Group Inc. (NYSE: UNH) was downgraded to Neutral from Buy with a $288 price target (versus a $266.54 close) at Citigroup.

Zscaler Inc. (NASDAQ: ZS) was downgraded to Neutral from Buy at BTIG.

Friday’s top analyst calls were in Apple, Caterpillar, Costco, GW Pharmaceuticals, NXP Semiconductors, Southwest Airlines, Teva Pharmaceutical, Ulta Beauty, Wells Fargo and many more.

Follow @Jonogg on Twitter to receive the daily analyst calls and other market research calls directly on your feed.